Furthermore, the DPP-IV inhibitory activity of these 12 CF species is reported for the first time, making them good candidates for bioassay- or metabolomic-guided isolation to obtain potential new natural agents for controlling DMII. Here, DPP4 is linked to cystic fibrosis.